Harry Kovelman, MD, has joined Myomo Inc as its Chief Medical Officer, according to the company in a media release.
In this role, Dr Kovelman will oversee Myomo’s patient advocacy organization, which helps ensure MyoPro patients’ clinical qualification for the brace and pursues insurance coverage. At Myomo, he will work closely with commercial and government payor organizations to continue to increase patient access to the MyoPro product line.
His 25 years of experience in medical devices and pharmaceuticals includes roles as Global Medical Director for Orthopedics at Ottobock Healthcare and Global Medical Affairs Director for Dynasplint Systems, as well as senior executive roles at Pacira Pharmaceuticals and Helius Medical Technologies.
In addition, he has authored several papers on rehabilitation procedures and has presented at numerous professional conferences on various innovations in healthcare products and services.
As a member of the company’s senior leadership team, Kovelman will communicate the company’s scientific message to the payor community, clinicians, and patients, lead medical activities and educational programs, participate in designing clinical studies of the company’s products, and manage its Scientific Advisory Board of leading clinical professionals in the fields of rehabilitation medicine, occupational therapy, neurology and pediatric medicine, the release continues.
“I’m pleased to welcome Dr Kovelman to Myomo as we continue to expand patient access to our life-changing technology, add to our clinical research, and educate additional medical professionals about the MyoPro product line. I’d also like to thank Dr Brandon Green, who has served in this role for the last four years and is fully supporting the transition in this Chief Medical Officer position.”
— Paul R. Gudonis, Myomo CEO
[Source(s): Myomo Inc, Business Wire]